RB status governs differential sensitivity to cytotoxic and molecularly-targeted therapeutic agents

Cell Cycle

Volumn 7, Issue 8, 2008, Pages 1095-1103

  Stengel, Kristy R ^b,c   Dean, Jeffry L ^a   Seeley, Sarah L ^a   Mayhew, Christopher N ^b   Knudsen, Erik S ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Cell cycle checkpoints; Chemotherapeutics; Ras; Retinoblastoma tumor suppressor (RB)

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; PHOSPHATIDYLINOSITOL 3 KINASE; UO 126;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG SENSITIVITY; DRUG TARGETING; FIBROBLAST; MOUSE; NONHUMAN; RETINOBLASTOMA; TUMOR SUPPRESSOR GENE;

EID: 43549118398     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.7.8.5737     Document Type: Article

References (37)